Petra Krause1, Sonja P Zahner1, Gisen Kim1, Raziyah B Shaikh1, Marcos W Steinberg1, Mitchell Kronenberg2. 1. Division of Developmental Immunology, La Jolla Institute for Allergy & Immunology, La Jolla, California. 2. Division of Developmental Immunology, La Jolla Institute for Allergy & Immunology, La Jolla, California. Electronic address: mitch@liai.org.
Abstract
BACKGROUND & AIMS: The pathogenesis of inflammatory bowel disease (IBD) is associated with a dysregulated mucosal immune response. Expression of the tumor necrosis factor (TNF) superfamily member 14 (TNFSF14, also known as LIGHT [homologous to lymphotoxins, exhibits inducible expression, and competes with HSV glycoprotein D for HVEM, a receptor expressed by T lymphocytes]) on T cells is involved in their activation; transgenic expression of LIGHT on T cells in mice promotes inflammation in multiple organs, including intestine. We investigated the roles for LIGHT in recovery from intestinal inflammation in mice. METHODS: We studied the role of LIGHT in intestinal inflammation using Tnfsf14(-/-) and wild-type mice. Colitis was induced by transfer of CD4(+)CD45RB(high) T cells into Rag1(-/-) or Tnfsf14(-/-)Rag1(-/-) mice, or by administration of dextran sulfate sodium to Tnfsf14(-/-) or wild-type C57BL/6J mice. Mice were weighed, colon tissues were collected and measured, and histology analyses were performed. We measured infiltrating cell populations and expression of cytokines, chemokines, and LIGHT. RESULTS: After administration of dextran sulfate sodium, Tnfsf14(-/-) mice developed more severe colitis than controls, based on their reduced survival, accelerated loss of body weight, and histologic scores. LIGHT protected mice from colitis via the lymphotoxin β receptor and was expressed mainly by myeloid cells in the colon. Colons of Tnfsf14(-/-) mice also had increased accumulation of innate immune cells and higher levels of cytokines than colons from control mice. LIGHT, therefore, appears to regulate inflammation in the colon. CONCLUSIONS: Tnfsf14(-/-) mice develop more severe colitis than control mice. LIGHT signals through the lymphotoxin β receptor in the colon to regulate the innate immune response and mediate recovery from intestinal inflammation.
BACKGROUND & AIMS: The pathogenesis of inflammatory bowel disease (IBD) is associated with a dysregulated mucosal immune response. Expression of the tumor necrosis factor (TNF) superfamily member 14 (TNFSF14, also known as LIGHT [homologous to lymphotoxins, exhibits inducible expression, and competes with HSVglycoprotein D for HVEM, a receptor expressed by T lymphocytes]) on T cells is involved in their activation; transgenic expression of LIGHT on T cells in mice promotes inflammation in multiple organs, including intestine. We investigated the roles for LIGHT in recovery from intestinal inflammation in mice. METHODS: We studied the role of LIGHT in intestinal inflammation using Tnfsf14(-/-) and wild-type mice. Colitis was induced by transfer of CD4(+)CD45RB(high) T cells into Rag1(-/-) or Tnfsf14(-/-)Rag1(-/-) mice, or by administration of dextran sulfate sodium to Tnfsf14(-/-) or wild-type C57BL/6J mice. Mice were weighed, colon tissues were collected and measured, and histology analyses were performed. We measured infiltrating cell populations and expression of cytokines, chemokines, and LIGHT. RESULTS: After administration of dextran sulfate sodium, Tnfsf14(-/-) mice developed more severe colitis than controls, based on their reduced survival, accelerated loss of body weight, and histologic scores. LIGHT protected mice from colitis via the lymphotoxin β receptor and was expressed mainly by myeloid cells in the colon. Colons of Tnfsf14(-/-) mice also had increased accumulation of innate immune cells and higher levels of cytokines than colons from control mice. LIGHT, therefore, appears to regulate inflammation in the colon. CONCLUSIONS:Tnfsf14(-/-) mice develop more severe colitis than control mice. LIGHT signals through the lymphotoxin β receptor in the colon to regulate the innate immune response and mediate recovery from intestinal inflammation.
Authors: K Tamada; K Shimozaki; A I Chapoval; Y Zhai; J Su; S F Chen; S L Hsieh; S Nagata; J Ni; L Chen Journal: J Immunol Date: 2000-04-15 Impact factor: 5.422
Authors: R B Shaikh; S Santee; S W Granger; K Butrovich; T Cheung; M Kronenberg; H Cheroutre; C F Ware Journal: J Immunol Date: 2001-12-01 Impact factor: 5.422
Authors: I A Rooney; K D Butrovich; A A Glass; S Borboroglu; C A Benedict; J C Whitbeck; G H Cohen; R J Eisenberg; C F Ware Journal: J Biol Chem Date: 2000-05-12 Impact factor: 5.157
Authors: Pritesh Desai; Vikas Tahiliani; Tarun E Hutchinson; Farhad Dastmalchi; Jessica Stanfield; Georges Abboud; Paul G Thomas; Carl F Ware; Jianxun Song; Michael Croft; Shahram Salek-Ardakani Journal: J Immunol Date: 2018-03-07 Impact factor: 5.422
Authors: Mona A Marie; Edward J Sanderlin; Swati Satturwar; Heng Hong; Kvin Lertpiriyapong; Deepak Donthi; Li V Yang Journal: Biochim Biophys Acta Mol Basis Dis Date: 2021-10-08 Impact factor: 5.187
Authors: Edward J Sanderlin; Nancy R Leffler; Kvin Lertpiriyapong; Qi Cai; Heng Hong; Vasudevan Bakthavatchalu; James G Fox; Joani Zary Oswald; Calvin R Justus; Elizabeth A Krewson; Dorcas O'Rourke; Li V Yang Journal: Biochim Biophys Acta Mol Basis Dis Date: 2016-12-07 Impact factor: 5.187
Authors: Ryan C Ungaro; Liangyuan Hu; Jiayi Ji; Shikha Nayar; Subra Kugathasan; Lee A Denson; Jeffrey Hyams; Marla C Dubinsky; Bruce E Sands; Judy H Cho Journal: Aliment Pharmacol Ther Date: 2020-11-01 Impact factor: 9.524
Authors: E Macho-Fernandez; E P Koroleva; C M Spencer; M Tighe; E Torrado; A M Cooper; Y-X Fu; A V Tumanov Journal: Mucosal Immunol Date: 2014-09-03 Impact factor: 7.313